Location History:
- Nr Saffron Walden, GB (2010)
- Bourn, GB (2020)
- Cambridge, GB (2007 - 2023)
Company Filing History:
5 out of 7 
3 out of 5 
3 out of 48 
Years Active: 2007-2024
Title: **Matthew Alan Gregory: A Pioneer in Succinate Prodrugs and Polyketide Synthesis**
Introduction
Matthew Alan Gregory is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the fields of medicinal chemistry and biotechnology. With an impressive portfolio of 18 patents, Gregory has been at the forefront of innovation, particularly in the development of compounds aimed at enhancing mitochondrial ATP production.
Latest Patents
Among Gregory's latest inventions is a novel succinate prodrug, which includes several forms such as salts, hydrates, and solvates, that are designed to be cell permeable. This compound shows great promise for increasing ATP production in mitochondria, making it relevant for medical treatments of various diseases, as well as applications in nutritional supplements, nutricosmetics, and cosmetics. Another notable patent focuses on methods for producing hybrid polyketide synthase genes and polyketides. This invention outlines processes for developing a library of cells that generate polyketides and selecting these strains based on their ability to bind to specific protein targets.
Career Highlights
Matthew Alan Gregory has worked at reputable organizations, including Neurovive Pharmaceutical AB and the Buck Institute for Research on Aging. His work has contributed significantly to advancements in pharmaceuticals and aging research, reflecting his commitment to improving health outcomes through innovative solutions.
Collaborations
Throughout his career, Gregory has collaborated with notable professionals, including Steven James Moss and Barrie Wilkinson. These partnerships have further enhanced his research capabilities and broadened his impact in the fields of drug development and biotechnological research.
Conclusion
Matthew Alan Gregory's extensive body of work highlights his role as a leading inventor in the area of succinate prodrugs and polyketide synthesis. His innovative approach and dedication to research underscore the potential for future breakthroughs in health and medicine, marking him as a notable figure in the landscape of modern invention.